Enterprise Together with KSC
DC Medical
Israel
Company Overview
Commercialization of the preterm birth diagnostic device which shows superior performance on accuracy, portability, test result drawing speed, affordability, diagnosable group compared to existing methods
Sectors
- Bio Medical
Project Summary
- Portable preterm birth diagnostic device using EIS technology
Business Model
- Revenue model Sales of the product/ Licensing out and royalty revenue
- Key Customer Health Authorities, University hospitals
Major Performance
-
Sales
- 2020-$10,000
-
Investment
- $9,651,623
- VCs,
- private investors
-
Employees
- 2021-9
-
Patent
- S. Korea(Granted 1)
- Global(Granted 1/ Applied 4)
- Trademarks(Granted 4/ Applied 6)
Overseas Expansion
Stage
Preparing for overseas expansion
Status
Preparing for multi-national clinical trials in Korea, Dubai, and Great Britain
Performance
- 1. Selected for the Dubai government program, Future Accelerator
- 2. Awarded on Johnson and Johnson QuickFire Challenge
Short-term goals in three years
- Finish multi-national clinical trials, approvals and launch our commercial product
Products / Services
1
2
- Target Country
- Israel
- Date of Establishment
- Aug 06, 2018
-
- info@dcmedical.co.kr info@dcmedical.co.kr
-
- Website
- http://dcmedical.co.kr/ http://dcmedical.co.kr/
-
- Location
- Seocho-gu, Seoul, Korea
-
- CEO
- Dabriel Cho
-
- Founder’s Background
-
- DC Medical, CEO(2018~Present)
- InterMedi Group, Founder & Board of Director(2017~Present)
- University of the Arts London, BA Arts, Design and Environment(2007~2010)